A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

July 31, 2026

Conditions
Substance UseHarm ReductionAdolescent Behavior
Interventions
BEHAVIORAL

iDECIDE

iDECIDE is a 4-session drug education and diversion program that addresses topics such as the neurobiology and addiction, adolescent brain development, industry tactics, motives for using substances, risk and protective factors, identifying triggers, healthy alternatives, core values, and long-term goal setting. These topics are taught via facilitated discussions, videos, worksheets, and handouts. The iDECIDE drug curriculum will be delivered weekly for 4 weeks via videoconference or in-person visits. Each session typically takes 60-75 minutes. For this study, facilitators are members of study staff.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts Department of Health

OTHER_GOV

lead

Massachusetts General Hospital

OTHER